Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12614000475640
Ethics application status
Approved
Date submitted
30/04/2014
Date registered
7/05/2014
Date last updated
7/05/2014
Type of registration
Prospectively registered
Titles & IDs
Public title
Retinal blood vessels in sleep apnea patients
Query!
Scientific title
Retinal vascular complications in obstructive sleep apnea patients
Query!
Secondary ID [1]
284506
0
Nil
Query!
Universal Trial Number (UTN)
N/A
Query!
Trial acronym
N/A
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Obstructive Sleep Apnea
291765
0
Query!
Condition category
Condition code
Eye
292123
292123
0
0
Query!
Diseases / disorders of the eye
Query!
Respiratory
292124
292124
0
0
Query!
Sleep apnoea
Query!
Intervention/exposure
Study type
Observational
Query!
Patient registry
False
Query!
Target follow-up duration
Query!
Target follow-up type
Query!
Description of intervention(s) / exposure
Non-invasive optical scanning of the retina. This will take approximately 15 minutes and will be a one-off scan.
Query!
Intervention code [1]
289264
0
Not applicable
Query!
Comparator / control treatment
Aged matched health volunteers
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
292003
0
Increased pulsatility index of retinal vessels in OSA patients. This will be assessed using post data capture analysis on retinal videos recorded from each individual. The pulse amplitude of both retinal artery and veins will be measured using custom algorithms in OSA and controls.
Query!
Assessment method [1]
292003
0
Query!
Timepoint [1]
292003
0
cross-sectional study, assessed at baseline only. We aim to recruit the target number of participants within 3 years.
Query!
Secondary outcome [1]
307984
0
Need of ocular screening for OSA patients. If significant results are obtained, using methodology described in the primary outcome a screening tool may be developed to screen the eyes in OSA patients for early diagnosis
Query!
Assessment method [1]
307984
0
Query!
Timepoint [1]
307984
0
3 years
Query!
Eligibility
Key inclusion criteria
1. OSA patients undergoing overnight diagnostic polysomnography will be included
2. Gender: M/F
3. Age range: 18+
4. Clear ocular media with visual acuity >= 6/12.
5. Not on previous ocular study trial.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
1. Women lactating, pregnant or of childbearing potential who are not willing to avoid becoming pregnant during the study.
2. Participants with a history of ocular disease(s) that are likely to interfere with the metabolism or excretion of test medications.
3. Participants with a history of a psychological illness or other conditions which may interfere with their ability to understand the study requirements.
Query!
Study design
Purpose
Screening
Query!
Duration
Cross-sectional
Query!
Selection
Case control
Query!
Timing
Both
Query!
Statistical methods / analysis
We will perform statistical analysis once we have recruited the target number of participants.
Our previous study on glaucoma and control subjects showed a mean difference of 8mm/s, 15 micrometers, 10% and 20 micrometers for retinal pulse wave propagation, vessel diameter, pulsatility index and retinal nerve fibre layer thickness respectively, between the two groups. Based on this, we computed the average effect size to be 0.3. With type-I error (alpha) of 0.05 and power of 0.95, a sample size of ~100 (50 in each group) will be sufficient to detect a difference between these two groups.
Query!
Recruitment
Recruitment status
Not yet recruiting
Query!
Date of first participant enrolment
Anticipated
19/05/2014
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
100
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
NSW
Query!
Recruitment hospital [1]
2367
0
Macquarie University Hospital - Macquarie Park
Query!
Recruitment postcode(s) [1]
8034
0
2113 - North Ryde
Query!
Recruitment postcode(s) [2]
8035
0
2109 - Macquarie University
Query!
Funding & Sponsors
Funding source category [1]
289149
0
University
Query!
Name [1]
289149
0
Macquarie University
Query!
Address [1]
289149
0
Balaclava Rd, North Ryde NSW 2113
Query!
Country [1]
289149
0
Australia
Query!
Primary sponsor type
University
Query!
Name
Macquarie University
Query!
Address
Balaclava Rd, North Ryde NSW 2113
Query!
Country
Australia
Query!
Secondary sponsor category [1]
287815
0
None
Query!
Name [1]
287815
0
Query!
Address [1]
287815
0
Query!
Country [1]
287815
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
290922
0
Macquarie University Human Research
Query!
Ethics committee address [1]
290922
0
Balaclava Rd, North Ryde, NSW 2109
Query!
Ethics committee country [1]
290922
0
Australia
Query!
Date submitted for ethics approval [1]
290922
0
Query!
Approval date [1]
290922
0
28/04/2014
Query!
Ethics approval number [1]
290922
0
5201400103
Query!
Summary
Brief summary
Obstructive sleep apnea (OSA) is a condition consisting of intermittent upper airway obstruction during sleep, leading to periods of hypoxia (reduced oxygen levels) and acute hypertension (high blood pressure). It has been hypothesized that in OSA, physiological changes can result in retinal ischemia (restriction in blood supply to tissues) and associated retinal vascular changes and progression of glaucomatous damage to the optic nerve. In a previous study, we did not find an increased prevalence of optic disc edema or other optic neuropathies in the OSA population. However, retinal vascular changes were more common in patients with severe OSA, independent of blood pressure, suggesting that OSA patients should undergo ophthalmologic screening. Despite this, the risk for various ocular disorders among patients with OSA remains unclear, particularly because in prior studies only static (single) measures of retinal vessels were considered. Additionally, these studies did not adequately control for potential confounders of these associations, such as obesity and hypertension. The aim of the current study is to investigate dynamic (real time videos) retinal vasculature characteristics in OSA patients and determine any associated changes of the retina in this group of patients. This will provide a new-insight into specific OSA related changes in the eye.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Attachments [1]
43
43
0
0
/AnzctrAttachments/366234-APPROVED_FRASER_5201400103_2.pdf
Query!
Query!
Contacts
Principal investigator
Name
47994
0
Dr Clare Fraser
Query!
Address
47994
0
Macquarie Eye Clinic, 2 Technology Place, Macquarie University, NSW 2109
Query!
Country
47994
0
Australia
Query!
Phone
47994
0
+61 2 9812 3933
Query!
Fax
47994
0
Query!
Email
47994
0
[email protected]
Query!
Contact person for public queries
Name
47995
0
Mojtaba Golzan
Query!
Address
47995
0
Australian School of Advanced Medicine
2 Technology Place, Macquarie University
NSW 2109
Query!
Country
47995
0
Australia
Query!
Phone
47995
0
+61 2 9850 2759
Query!
Fax
47995
0
Query!
Email
47995
0
[email protected]
Query!
Contact person for scientific queries
Name
47996
0
Mojtaba Golzan
Query!
Address
47996
0
Australian School of Advanced Medicine
2 Technology Place, Macquarie University
NSW 2109
Query!
Country
47996
0
Australia
Query!
Phone
47996
0
+61 2 9850 2759
Query!
Fax
47996
0
Query!
Email
47996
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF